CCocoon Bioscience
Cocoon Bioscience is a Bilbao-area biomanufacturing startup that uses its proprietary CrisBio® insect-based expression platform (moth cocoons as bioreactors) to produce specialty recombinant enzymes and high-performance growth factors at low cost. Spun off in 2022 from Algenex (following Algenex's sale to Insud Pharma), it serves life-science customers (mRNA/IVT synthesis, sequencing enzymes) as well as the alternative-protein/cultivated-meat industry. The company has raised roughly $17.9M across two 2023 rounds from investors including Columbus Venture Partners, Cleon Capital and North South Ventures, and is led by CEO Joshua Robinson.
SectorsBiotechnology, Biomanufacturing, Enzymes, Alternative protein / Cultivated meat
Start-up MapHealthtech & Bio › Biologics manufacturing & CDMO
Founders
J
Joshua Robinson
CEO
Global models 4
GGeltor
United States · geltor.com ↗
Makes recombinant proteins on its own expression platform and sells them business-to-business as specialty ingredients, much like Cocoon's model of selling proteins made on its own platform.
~$114MComparable
LLiberation Labs
United States · www.liberationlabs.com ↗
Builds low-cost manufacturing capacity for recombinant proteins and sells the output to food-tech and life-science customers, going after the same 'cheaper protein production' opportunity as Cocoon.
~$100MComparable
AArzeda
United States · www.arzeda.com ↗
Designs and makes speciality enzymes and proteins for industrial and life-science buyers, the same kind of enzyme supply Cocoon provides.
~$53MComparable
FFuture Fields
Canada · www.futurefields.io ↗
Uses insects (fruit flies) as living bioreactors to make recombinant growth factors cheaply for cultivated meat and biotech, the closest match to Cocoon's moth-cocoon CrisBio platform.
~$10MComparable
In the same niche 8 others
See all in the Start-ups Map →
Notes: Most funded first
Investors 8
Open as list →
CColumbus Venture Partners
columbusvp.com
MMONDRAGON Ventures
mondragon-corporation.com
SSPRI
www.spri.eus
V
Viscofan
www.viscofan.com
BBexen Medical
CCleon Capital
NNorth South Ventures
SSangha Capital
Funding rounds 2
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2023-11-03 | Series A | €2M |
Mondragon Corporation, Bexen Medical
+6 more
|
| 2023-03-14 | Series A (estimated) | €15M |
Columbus Venture Partners
+5 more
|
News 1
Open as list →| Published | Article |
|---|---|
| 2023-11-03 |
MONDRAGON, Columbus Venture Partners y Cleon Capital lideran una ronda de €2 millones en Cocoon Bioscience ↗
Capital-Riesgo.es
2023-11-03 |